Fully Automated, Robotic Radiation Protection System Reduces Exposure by 90%

Fluoroscopy-guided procedures have become a leading source of occupational ionizing radiation exposure for healthcare providers. Currently available radiation protection solutions have limitations - leaving gaps in full body coverage, providing reduced protection to staff, and creating obstructions that can limit access to the patient. Now, a novel radiation shield system, which is the only fully automated and integrated, head-to-toe shielding device that blocks radiation scatter at its source, could be potentially life-saving for physicians and staff.

With Radiaction Medical, Ltd.’s (Tel Aviv, Israel) Radiation Shielding System, physicians can deploy a radiation shielding device at the touch of a button, fully protecting themselves and their staff. Radiaction’s technology blocks the threat of radiation exposure during fluoroscopy-guided procedures. Clinical studies have shown that the Shield System can reduce radiation scatter to the entire interventional lab by over 90%, with even higher reductions to the heads and upper bodies of the treating physicians. Since its market debut in Spring 2022, the Radiaction Shield System stands alone as the only fully automated and integrated, head-to-toe shielding device that blocks radiation scatter at its source.

Radiaction Medical has now received an additional 510(k) Clearance from the Food and Drug Administration (FDA) for its Radiation Shielding System, one that enables compatibility with the Siemens Artis family of fluoroscopy C-Arm machines. The Shield System functions as an accessory to new and legacy C-arm models. Building upon its previous clearance with Toshiba Infinix-I systems, this latest authorization permits the Shield System to be used in a greater number of interventional cardiology and electrophysiology labs across the U.S., expanding the availability of Radiaction’s potentially life-saving radiation shield to yet more physicians and staff.

“The reactions to our Shield System technology and capabilities have been extremely encouraging. Awareness has been growing about the negative implications of staff radiation exposure in interventional labs, but until now, there was no meaningful, comprehensive way to address the problem,” said Jonathan Yifat, Radiaction’s CEO. “We are now in a historic position and uniquely poised to drive a truly novel, integrated, and automated solution to market, and directly into the hands of the dedicated healthcare providers at all levels delivering top-tier patient care.”

Related Links:
Radiaction Medical, Ltd.